Evertex Fabrinology Ltd (1470) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Evertex Fabrinology Ltd stock TWD 13.03, price TWD 23.45, that is 44.4% below the price, quality 65 out of 100. Rating: strongly overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range 13.04 TWD – 25.59 TWD · fair‑value band 10.17 TWD – 16.94 TWD · the 23.45 TWD price screens above the 13.03 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Evertex Fabrinology in your weekly email
Every Wednesday you see whether Evertex Fabrinology is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
evertex fabrinology limited engages in dyeing and finishing of textile products in Taiwan, Vietnam, Bengal, China, Cambodia, Indonesia, and internationally.
Show moreShow less
The company offers Janerino, a hybrid merino wool fabric; BulkyStretch, a mono-material knit fabric; Syncellux, a cellulose synthetic blend fabric; and Tonissimo, a synthetic fleece fabric.
It also provides functional fabrics; and fabrics for trims, pocket, and collar liners, as well as linings for casual and outdoor wears. The company was formerly known as Evertex Dyeing & Finishing. evertex fabrinology limited was founded in 1986 and is based in Taipei, Taiwan.
Stock analysis
Evertex Fabrinology Ltd (1470) currently trades at 23.45 TWD, while our model-based Fair Value estimate is 13.03 TWD, 44% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 18.36 TWD per share, and 0 of the 24 models we run sit above the 23.45 TWD price.
Bear case: the Asset-Based group reads lowest at 5.46 TWD, and 24 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: 10.17 TWD (bear) to 16.94 TWD (bull), the price of 23.45 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Consumer Cyclical sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Evertex Fabrinology Ltd reported revenue of 804M TWD in FY2025 versus 895M TWD in FY2021, a compound −2.6%/yr. Reported net income was 67.3M TWD in FY2025, compounding +0.8%/yr from FY2021.
Key figures
Market cap 2.0B TWD (≈ $62.4M) Micro · P/E ratio 18.2 · P/S ratio 2.69 · EPS (TTM) 1.29 TWD · Dividend yield 2.8% · Net margin 14.6% · Return on equity 11.4% · Return on assets (EBIT) 5.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (medium confidence).
What moves the price
The share trades about 6% below its 52-week high and 15% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −8% fair-value upside, at −44%, 1470 screens richer than that median.
Fair Value models
Bear10.17 TWDFair Value 13.03 TWDBull16.94 TWD
Price 23.45 TWD · Downside -44.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.5488 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.74/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+2.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.0%
Start year 2020 (pandemic). Over 10 years: +0.5% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+3.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.6%
Dividend (yield on the price)2.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.0.6% vs 0.9%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 10%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+16.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +14.3% a year for the price.
Compare Evertex Fabrinology Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 336 stocks
Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score65 · Top 25%
Fair Value upside−44.4% · Below median
Profitability
Return on equity (12 months)11.4% · Top 25%
Return on assets5.8% · Top 25%
Net margin (12 months)14.6% · Top 25%
Operating margin (12 months)12.7% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)−9.2% · Bottom 25%
Dividend yield (12 months)2.8% · Above median
Valuation Multiplesvs Textile Manufacturing median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Evertex Fabrinology Ltd (1470) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 13.03 TWD versus a price of 23.45 TWD, about 44% lower (overvalued).
What is the fair value of 1470?
Our model-based fair value for Evertex Fabrinology Ltd is 13.03 TWD (as of Nov 4, 2026), built from audited fundamentals. The current price: 23.45 TWD.
What is the quality score of 1470?
Evertex Fabrinology Ltd has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Evertex Fabrinology Ltd (1470)?
Our model-based price target is the fair value of 13.03 TWD (as of Nov 4, 2026) from 24 valuation models. Cautious scenario 10.17 TWD, optimistic scenario 16.94 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Evertex Fabrinology Ltd stock forecast for 2026?
Our models put fair value at 13.03 TWD, about 44% lower versus a price of 23.45 TWD (overvalued). Cautious scenario 10.17 TWD, optimistic scenario 16.94 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Evertex Fabrinology Ltd (1470)?
Evertex Fabrinology Ltd reported trailing-twelve-month revenue of about 763M TWD (latest available figure, as of Nov 4, 2026).
Does Evertex Fabrinology Ltd pay a dividend?
Evertex Fabrinology Ltd currently shows a dividend yield of 2.77% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Evertex Fabrinology Ltd (1470) and when is the ex-dividend date?
Evertex Fabrinology Ltd pays a dividend of 0.65 TWD per share a year, a dividend yield of 2.8%. The last ex-dividend date was Jul 1, 2026. A dividend has been paid every year since 2014. The payout ratio is 50.4% of earnings. Free cash flow covers the dividend 1.41 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Evertex Fabrinology Ltd (1470)?
For today's price to be fair in a discounted-cash-flow model, Evertex Fabrinology Ltd would have to grow free cash flow by +16.1 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.0 % per year. As of Nov 4, 2026.
What discount rate (WACC) does the fair value of 1470 use?
Our models discount Evertex Fabrinology Ltd at 11.8 %: a base by market capitalisation (micro), damped by beta 0.15, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Evertex Fabrinology Ltd that is +16.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Evertex Fabrinology Ltd (1470) delivered so far?
Over the past 5 years revenue at Evertex Fabrinology Ltd grew +5.0 % a year. The price currently implies free-cash-flow growth of +16.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Evertex Fabrinology Ltd (1470) growing?
The median revenue growth in the sector is +4.8 % a year. That is the yardstick for the growth priced into Evertex Fabrinology Ltd (+16.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Evertex Fabrinology Ltd (1470)?
The free-cash-flow yield on the price is 3.84 %: that much free cash flow Evertex Fabrinology Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Evertex Fabrinology Ltd (1470)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Evertex Fabrinology Ltd it is 13.03 TWD per share (as of Nov 4, 2026), against a price of 23.45 TWD. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Evertex Fabrinology Ltd stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 1470 trades above its calculated fair value: price 23.45 TWD, fair value 13.03 TWD, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 1470?
No. The price is what the market pays today (23.45 TWD); the fair value is what the company's own numbers justify (13.03 TWD). For Evertex Fabrinology Ltd the two are 10.42 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Evertex Fabrinology Ltd worth?
The market values Evertex Fabrinology Ltd at about 2.0B TWD (market capitalisation, as of Nov 4, 2026). Per share that is 23.45 TWD; our models calculate a fair value of 13.03 TWD per share.
What do the bullish and bearish scenarios say about 1470?
Our models span a range for Evertex Fabrinology Ltd: cautious scenario 10.17 TWD, base 13.03 TWD, optimistic 16.94 TWD per share (as of Nov 4, 2026, price 23.45 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 1470?
Evertex Fabrinology Ltd trades at a price-to-earnings ratio of 18.2 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 13.03 TWD is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 32.2. Other multiples: P/B 2.0, P/S 2.7, EV/EBITDA 14.1.
How solid is the balance sheet of Evertex Fabrinology Ltd (1470)?
Balance-sheet figures for Evertex Fabrinology Ltd (as of Nov 4, 2026): return on equity 11.4%. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is 1470 from its 52-week high?
Evertex Fabrinology Ltd trades at 23.45 TWD, about 6% below its 52-week high of 24.85 TWD and 15% above the low of 20.46 TWD (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 13.03 TWD is for.
Which stocks are comparable to Evertex Fabrinology Ltd?
From the same area (Consumer Cyclical) we also value Tongkun Group, Shenzhou International Group, Inner Mongolia ERDOS Resources Co, Far Eastern New Century Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Evertex Fabrinology Ltd stock attractive at the current price?
The data as of Nov 4, 2026: price 23.45 TWD, calculated fair value 13.03 TWD (−44%), Quality Score 65/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 1470 calculated?
We run Evertex Fabrinology Ltd through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 13.03 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Evertex Fabrinology Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Evertex Fabrinology Ltd (1470)?
The closing price on Nov 9, 2026 was 23.45 TWD. Our model-based fair value is 13.03 TWD, about 44% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Evertex Fabrinology Ltd right now?
The price sits above even our optimistic bull case (16.94 TWD). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Evertex Fabrinology Ltd (1470) come from?
Earnings per share at Evertex Fabrinology Ltd grew +2.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share +0.3 %, EBIT margin +0.4 %, tax rate +0.0 %, residual (interest, one-offs) +1.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Evertex Fabrinology Ltd
How large is the market capitalisation of Evertex Fabrinology Ltd (1470)?
The market capitalisation of Evertex Fabrinology Ltd is 2.0B TWD (≈ $62.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Evertex Fabrinology Ltd (1470)?
The price-to-sales ratio of Evertex Fabrinology Ltd is 2.69 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Evertex Fabrinology Ltd (1470)?
Earnings per share at Evertex Fabrinology Ltd are 1.29 TWD (price ÷ EPS = P/E 18.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Evertex Fabrinology Ltd (1470)?
The dividend yield of Evertex Fabrinology Ltd is 2.8% (payout 50.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Evertex Fabrinology Ltd (1470)?
The net margin of Evertex Fabrinology Ltd is 14.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Evertex Fabrinology Ltd (1470)?
The return on equity (ROE) of Evertex Fabrinology Ltd is 11.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Evertex Fabrinology Ltd (1470)?
On an EBIT basis the return on assets of Evertex Fabrinology Ltd is 5.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Evertex Fabrinology Ltd (1470)?
The operating margin of Evertex Fabrinology Ltd is 12.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Evertex Fabrinology Ltd (1470)?
Revenue at Evertex Fabrinology Ltd is growing −9.2% versus a year earlier (3y avg −1.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Evertex Fabrinology Ltd (1470)?
Earnings per share at Evertex Fabrinology Ltd are growing +35.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Evertex Fabrinology Ltd (1470) hold?
Evertex Fabrinology Ltd holds more cash than debt, 191M TWD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Evertex Fabrinology Ltd in the live analysis
One click puts Evertex Fabrinology Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 4, 2026